Abstract
Purpose
Patients with biliary atresia (BA) and cytomegalovirus (CMV) infection may have poorer outcomes after Kasai portoenterostomy (KPE) than uninfected patients, suggesting a rationale for antiviral treatment (AVT). We aimed to describe the incidence of CMV infection and of AVT in BA patients, and to detect any differences between infected and uninfected patients to conclude if AVT is of use.
Methods
Data on BA patients who underwent KPE 2004–2020 were retrospectively collected, and the outcome was analyzed with regard to CMV status.
Results
Fifteen out of forty-six (33%) BA patients had signs of ongoing CMV infection. They did not differ significantly from the CMV-negative patients regarding rate of prematurity, birth weight, or biochemical markers but were slightly older at KPE. All patients received steroids postoperatively and all patients with ongoing CMV infection received AVT with very good effect on viremia and without major side effects. The AVT consisted of oral valganciclovir (10–40 (– 58) mg/kg/d) or intravenous ganciclovir (5.3–11 mg/kg/d).
Conclusion
Ongoing CMV infection is common in this group of patients. The viremia can effectively be treated with AVT without any major side effects. Larger, randomized studies are needed to clarify the possible effect on clinical outcome.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Davenport M, Kerkar N, Mieli-Vergani G, Mowat AP, Howard ER (1997) Biliary atresia: the King’s College Hospital Experience (1974–1995). J Pediatr Surg 32:479–485. https://doi.org/10.1016/S0022-3468(97)90611-4
Nio M, Sano N, Ishii T, Sasaki H, Hayashi Y, Ohi R (2006) Long-term outcome in type I biliary atresia. J Pediatr Surg 41:1973–1975. https://doi.org/10.1016/j.jpedsurg.2006.08.019
Chardot C, Buet C, Serinet M-O, Golmard J-L, Lachaux A, Roquelaure B et al (2013) Improving outcomes of biliary atresia: French national series 1986–2009. J Hepatol 58:1209–1217. https://doi.org/10.1016/j.jhep.2013.01.040
Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K (2003) Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese biliary atresia registry. J Pediatr Surg 38:997–1000. https://doi.org/10.1016/S0022-3468(03)00178-7
Ohi R (2001) Surgery for biliary atresia: surgery for biliary atresia. Liver 21:175–182. https://doi.org/10.1034/j.1600-0676.2001.021003175.x
Chen S-M (2006) Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics 117:1147–1154. https://doi.org/10.1542/peds.2005-1267
Song Z, Dong R, Shen Z, Chen G, Yang Y, Zheng S (2017) Surgical outcome and etiologic heterogeneity of infants with biliary atresia who received Kasai operation less than 60 days after birth: a retrospective study. Medicine (Baltimore) 96:e7267. https://doi.org/10.1097/MD.0000000000007267
Tiao M-M, Tsai S-S, Kuo H-W, Chen C-L, Yang C-Y (2007) Epidemiological features of biliary atresia in Taiwan, a national study 1996–2003. J Gastroenterol Hepatol. https://doi.org/10.1111/j.1440-1746.2007.05114.x
Wada H, Muraji T, Yokoi A, Okamoto T, Sato S, Takamizawa S et al (2007) Insignificant seasonal and geographical variation in incidence of biliary atresia in Japan: a regional survey of over 20 years. J Pediatr Surg 42:2090–2092. https://doi.org/10.1016/j.jpedsurg.2007.08.035
Fischler B, Haglund B, Hjern A (2002) A population-based study on the incidence and possible pre- and perinatal etiologic risk factors of biliary atresia. J Pediatr 141:217–222. https://doi.org/10.1067/mpd.2002.126001
Hopkins PC, Yazigi N, Nylund CM (2017) Incidence of biliary atresia and timing of hepatoportoenterostomy in the United States. J Pediatr 187:253–257. https://doi.org/10.1016/j.jpeds.2017.05.006
Perlmutter DH, Shepherd RW (2002) Extrahepatic biliary atresia: A disease or a phenotype? Extrahepatic biliary atresia: a disease or a phenotype? Hepatology 35:1297–1304. https://doi.org/10.1053/jhep.2002.34170
McDiarmid SV, Anand R, Lindblad AS, The SPLIT Research Group (2004) Studies of pediatric liver transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 8:284–294. https://doi.org/10.1111/j.1399-3046.2004.00153.x
Zani A, Quaglia A, Hadzić N, Zuckerman M, Davenport M (2015) Cytomegalovirus-associated biliary atresia: an aetiological and prognostic subgroup. J Pediatr Surg 50:1739–1745. https://doi.org/10.1016/j.jpedsurg.2015.03.001
Fischler B, Ehrnst A, Forsgren M, Örvell C, Nemeth A (1998) The Viral Association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 27:57–64. https://doi.org/10.1097/00005176-199807000-00010
Fischler B, Woxenius S, Nemeth A, Papadogiannakis N (2005) Immunoglobulin deposits in liver tissue from infants with biliary atresia and the correlation to cytomegalovirus infection. J Pediatr Surg 40:541–546. https://doi.org/10.1016/j.jpedsurg.2004.11.035
Xu Y, Yu J, Zhang R, Yin Y, Ye J, Tan L et al (2012) The perinatal infection of cytomegalovirus is an important etiology for biliary atresia in China. Clin Pediatr (Phila) 51:109–113. https://doi.org/10.1177/0009922811406264
Parolini F, Hadzic N, Davenport M (2019) Adjuvant therapy of cytomegalovirus IgM + ve associated biliary atresia: prima facie evidence of effect. J Pediatr Surg 54:1941–1945. https://doi.org/10.1016/j.jpedsurg.2018.12.014
Shen C, Zheng S, Wang W, Xiao X-M (2008) Relationship between prognosis of biliary atresia and infection of cytomegalovirus. World J Pediatr 4:123–126. https://doi.org/10.1007/s12519-008-0024-8
Zhao Y, Xu X, Liu G, Yang F, Zhan J (2021) Prognosis of biliary atresia associated with cytomegalovirus: a meta-analysis. Front Pediatr 9:710450. https://doi.org/10.3389/fped.2021.710450
Fischler B, Svensson JF, Nemeth A (2009) Early cytomegalovirus infection and the long-term outcome of biliary atresia. Acta Paediatr 98:1600–1602. https://doi.org/10.1111/j.1651-2227.2009.01416.x
Fischler B, Czubkowski P, Dezsofi A, Liliemark U, Socha P, Sokol RJ et al (2022) Incidence, impact and treatment of ongoing CMV infection in patients with biliary atresia in four European centres. J Clin Med 11:945. https://doi.org/10.3390/jcm11040945
Kullberg-Lindh C, Olofsson S, Brune M, Lindh M (2008) Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA. Transpl Infect Dis 10:308–315. https://doi.org/10.1111/j.1399-3062.2008.00313.x
Swedish Medical Birth Register [database online]. Socialstyrelsen n.d. https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/medicinska-fodelseregistret/. Accessed 7 Jan 2021
De Tommaso AM, Andrade PD, Costa SC, Escanhoela CA, Hessel G (2005) High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis. BMC Infect Dis 5:108. https://doi.org/10.1186/1471-2334-5-108
Moore SW, Zabiegaj-Zwick C, Nel E (2012) Problems related to CMV infection and biliary atresia. S Afr Med J 102:890. https://doi.org/10.7196/SAMJ.6163
Tarr PI, Haas JE, Christie DL (1996) Biliary atresia, cytomegalovirus, and age at referral. Pediatrics 97:828–831
Fjaer RB, Bruu A-L, Nordbø SA (2005) Extrahepatic bile duct atresia and viral involvement. Pediatr Transplant 9:68–73. https://doi.org/10.1111/j.1399-3046.2005.00257.x
Zhao D, Gong X, Li Y, Sun X, Chen Y, Deng Z et al (2021) Effects of cytomegalovirus infection on the differential diagnosis between biliary atresia and intrahepatic cholestasis in a Chinese large cohort study. Ann Hepatol 23:100286. https://doi.org/10.1016/j.aohep.2020.100286
Goel A, Chaudhari S, Sutar J, Bhonde G, Bhatnagar S, Patel V et al (2018) Detection of cytomegalovirus in liver tissue by polymerase chain reaction in infants with neonatal cholestasis. Pediatr Infect Dis J 37:632–636. https://doi.org/10.1097/INF.0000000000001889
Fischler B, Rodensjo P, Nemeth A, Forsgren M, Lewensohn-Fuchs I (1999) Cytomegalovirus DNA detection on Guthrie cards in patients with neonatal cholestasis. Arch Dis Child - Fetal Neonatal Ed 80:F130–F134. https://doi.org/10.1136/fn.80.2.F130
Chiu C-Y, Chen P-H, Chan C-F, Chang M-H, Wu T-C (2013) Biliary atresia in preterm infants in Taiwan: a nationwide survey. J Pediatr 163:100-103.e1. https://doi.org/10.1016/j.jpeds.2012.12.085
van Wessel DBE, Boere T, Hulzebos CV, de Kleine RHJ, Verkade HJ, Hulscher JBF (2017) Preterm infants with biliary atresia: a nationwide cohort analysis from The Netherlands. J Pediatr Gastroenterol Nutr 65:370–374. https://doi.org/10.1097/MPG.0000000000001692
Wong Z, Davenport M (2019) What happens after Kasai for biliary atresia? A European multicenter survey. Eur J Pediatr Surg 29:001–006. https://doi.org/10.1055/s-0038-1668146
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Data collection and analysis were performed by UL. The first draft of the manuscript was written by UL and all authors contributed to previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liliemark, U., Svensson, J.F. & Fischler, B. Incidence and antiviral treatment of cytomegalovirus infection in infants with biliary atresia. Pediatr Surg Int 39, 117 (2023). https://doi.org/10.1007/s00383-023-05394-1
Accepted:
Published:
DOI: https://doi.org/10.1007/s00383-023-05394-1